PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 22, 2026Pathogens0 citationsOpen Access

Antifungal Susceptibility of Meyerozyma guillermondii Clinical Isolates from 1994 to 2014

Antifungal Susceptibility of Clinical Meyerozyma guillermondii Isolates Obtained Between 1994 and 2014: Original Research and Comparison with Published Data

View Full Paper
Ask AI
Bookmark
Share

Authors

AGAleksandra GórzyńskaDKDaria KonarskaAKAgnieszka Korzenowska-Kowal

Discussion

Loading...

Member takes

Overview

Original research shows antifungal susceptibility patterns in Meyerozyma guillermondii, suggesting concerns for azole resistance.

Key Points

  • This research aims to determine the antifungal susceptibility of Meyerozyma guillermondii isolates to various antifungal agents.
  • Analyzed 20 clinical isolates identified by MALDI-TOF and sequenced for ITS1-2 region.
  • Tested susceptibility to 12 antifungal drugs using the MICRONAUT–AT test and EUCAST microdilution method.
  • Included comparisons with published susceptibility data.
  • Isolates showed low MIC values for amphotericin B and flucytosine, except one with high MIC.
  • Resistance was noted in one isolate for all tested azoles.
  • Low MIC values for manogepix indicate its potential efficacy against Meyerozyma guillermondii.

Cite This Study

Górzyńska et al. (2026) studied this question.

synapsesocial.com/papers/699a9d8e482488d673cd3790https://doi.org/10.3390/pathogens15020235
View Full Paper
Ask AI
Bookmark
Share